ALTAMIRA THERAPEUTICS LTD's ticker is and the CUSIP is G0360L209. A total of 10 filers reported holding ALTAMIRA THERAPEUTICS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 829,000 | $202,691 | 0.00% |
Cutler Group LLC / CA | 10 | $0 | 0.00% |
Stonebridge Capital Advisors LLC | 5 | $1 | 0.00% |
WELLS FARGO & COMPANY/MN | 25 | $6 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 298 | $72 | 0.00% |
MORGAN STANLEY | 500 | $122 | 0.00% |
Citadel Advisors | 39,165 | $9,447 | 0.00% |
XTX Topco Ltd | 10,131 | $2,444 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 10,185 | $2,457 | 0.00% |
This page lists ALTAMIRA THERAPEUTICS LTD's shareholders in Q3 2023. To view ALTAMIRA THERAPEUTICS LTD's shareholder history, click here.